Janssen Submits Application to U.S. FDA Seeking Approval of DARZALEX ® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news